Viewing Study NCT01576692


Ignite Creation Date: 2025-12-24 @ 3:45 PM
Ignite Modification Date: 2026-01-05 @ 5:22 PM
Study NCT ID: NCT01576692
Status: COMPLETED
Last Update Posted: 2018-11-15
First Post: 2012-04-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma
Sponsor: St. Jude Children's Research Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent neuroblastoma View
None refractory neuroblastoma View
None natural killer cells View